| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 1.09e-08 | 67 | 128 | 8 | GO:0031492 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.34e-08 | 98 | 128 | 9 | GO:0031491 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 2.60e-07 | 100 | 128 | 8 | GO:0030527 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.31e-06 | 167 | 128 | 9 | GO:0031490 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH6 ABCA2 MYH7B PEX1 ABCC5 NUBP1 CCT4 BLM DDX46 MDN1 NAV3 NAV2 ATP1A2 DNAH5 | 9.37e-06 | 614 | 128 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 PEX1 ABCC5 NUBP1 CCT4 BLM DDX46 MDN1 NAV3 NAV2 ATP1A2 DNAH5 | 2.73e-05 | 441 | 128 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA2 DRG2 PEX1 ABCC5 NUBP1 CCT4 GTPBP10 RGS12 BLM DDX46 MDN1 NAV3 NAV2 ATP1A2 DNAH5 ADSS1 | 3.68e-05 | 775 | 128 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | adenylosuccinate synthase activity | 4.08e-05 | 2 | 128 | 2 | GO:0004019 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA2 DRG2 PEX1 ABCC5 NUBP1 CCT4 GTPBP10 RGS12 BLM DDX46 MDN1 NAV3 NAV2 ATP1A2 DNAH5 ADSS1 | 9.37e-05 | 839 | 128 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA2 DRG2 PEX1 ABCC5 NUBP1 CCT4 GTPBP10 RGS12 BLM DDX46 MDN1 NAV3 NAV2 ATP1A2 DNAH5 ADSS1 | 9.50e-05 | 840 | 128 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA2 DRG2 PEX1 ABCC5 NUBP1 CCT4 GTPBP10 RGS12 BLM DDX46 MDN1 NAV3 NAV2 ATP1A2 DNAH5 ADSS1 | 9.50e-05 | 840 | 128 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNA MYH2 FLNB MYH6 MSRB1 MYLK MAP2 MYH7B CAPN6 SPAG9 BICD1 AFAP1 PAFAH1B1 CCSER2 NAV3 FSCN1 USH2A ADSS1 | 2.26e-04 | 1099 | 128 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | 2.64e-04 | 479 | 128 | 11 | GO:0003779 | |
| GeneOntologyMolecularFunction | chromatin binding | H1-10 MTF2 ASH1L HNRNPC HP1BP3 H1-8 H1-2 H1-3 H1-4 H1-5 H1-1 GRHL3 WDR13 NUP153 | 2.82e-04 | 739 | 128 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 6.34e-04 | 61 | 128 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | actin filament binding | 6.60e-04 | 227 | 128 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.70e-03 | 37 | 128 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | structural molecule activity | H1-10 MAP2 MRPL27 EVPL HP1BP3 BICD1 H1-8 AHNAK H1-2 H1-3 H1-4 H1-5 H1-1 NUP153 | 1.74e-03 | 891 | 128 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.84e-03 | 38 | 128 | 3 | GO:0000146 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination | 1.79e-09 | 55 | 129 | 8 | GO:0045910 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | FOXM1 H1-10 ZBTB38 SLF1 CEBPG POLH CCT4 HNRNPC BLM ATXN7L3 H1-8 MORF4L2 H1-2 H1-3 H1-4 H1-5 FGF2 H1-1 GREM1 | 2.33e-09 | 564 | 129 | 19 | GO:0051052 |
| GeneOntologyBiologicalProcess | chromosome condensation | 1.89e-08 | 48 | 129 | 7 | GO:0030261 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 2.74e-07 | 142 | 129 | 9 | GO:0034728 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 4.36e-07 | 150 | 129 | 9 | GO:0000018 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA metabolic process | 5.76e-07 | 155 | 129 | 9 | GO:0051053 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 9.97e-07 | 122 | 129 | 8 | GO:0006334 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | FOXM1 H1-10 ZBTB38 SLF1 CEBPG POLH CCT4 HNRNPC BLM ATXN7L3 H1-8 MORF4L2 H1-2 H1-3 H1-4 H1-5 FGF2 H1-1 GREM1 HERC2 CDC5L | 3.48e-06 | 1081 | 129 | 21 | GO:0006259 |
| GeneOntologyBiologicalProcess | maintenance of centrosome location | 4.71e-06 | 6 | 129 | 3 | GO:0051661 | |
| GeneOntologyBiologicalProcess | chromatin organization | H1-10 SLF1 CEBPG MTF2 ASH1L HNRNPC HP1BP3 USP21 ATXN7L3 H1-8 MORF4L2 SETBP1 H1-2 H1-3 H1-4 RBM14 H1-5 H1-1 | 1.20e-05 | 896 | 129 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H1-10 SLF1 CEBPG MTF2 ASH1L HNRNPC HP1BP3 USP21 ATXN7L3 H1-8 MORF4L2 SETBP1 H1-2 H1-3 H1-4 RBM14 H1-5 H1-1 | 5.04e-05 | 999 | 129 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | H1-10 CEBPG MTF2 ASH1L HNRNPC HP1BP3 USP21 H1-8 SETBP1 H1-2 H1-3 H1-4 RBM14 H1-5 H1-1 | 6.22e-05 | 741 | 129 | 15 | GO:0006338 |
| GeneOntologyBiologicalProcess | maintenance of organelle location | 6.53e-05 | 13 | 129 | 3 | GO:0051657 | |
| GeneOntologyBiologicalProcess | centrosome localization | 6.58e-05 | 35 | 129 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 7.37e-05 | 36 | 129 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | chromosome organization | CHMP4C H1-10 FLNA SLF1 CCT4 HNRNPC BLM H1-8 H1-2 H1-3 H1-4 H1-5 NAV2 H1-1 | 1.02e-04 | 686 | 129 | 14 | GO:0051276 |
| GeneOntologyBiologicalProcess | DNA recombination | 1.08e-04 | 368 | 129 | 10 | GO:0006310 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.48e-04 | 127 | 129 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | negative regulation of cell division | 1.52e-04 | 17 | 129 | 3 | GO:0051782 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 1.75e-04 | 249 | 129 | 8 | GO:0065004 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | CHMP4C FLNA MAP2 CAPN6 ARHGEF18 NUBP1 BICD1 PAFAH1B1 RBM14 NAV3 GRHL3 FSCN1 | 2.83e-04 | 579 | 129 | 12 | GO:0051493 |
| GeneOntologyCellularComponent | nucleosome | 1.43e-08 | 138 | 129 | 10 | GO:0000786 | |
| GeneOntologyCellularComponent | supramolecular fiber | CHMP4C FLNA MYH2 FLNB MYH6 MAP2 MYH7B CAPN6 EVPL CCT4 TPGS2 BICD1 AFAP1 AHNAK PAFAH1B1 ASPM NAV3 AK1 DNAH5 AHNAK2 | 3.59e-05 | 1179 | 129 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CHMP4C FLNA MYH2 FLNB MYH6 MAP2 MYH7B CAPN6 EVPL CCT4 TPGS2 BICD1 AFAP1 AHNAK PAFAH1B1 ASPM NAV3 AK1 DNAH5 AHNAK2 | 3.95e-05 | 1187 | 129 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | apical dendrite | 4.35e-05 | 32 | 129 | 4 | GO:0097440 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNA MYH2 FLNB MYH6 MSRB1 MYLK MAP2 MYH7B ITSN1 HNRNPC AFAP1 AHNAK FSCN1 | 5.86e-05 | 576 | 129 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | euchromatin | 8.32e-05 | 72 | 129 | 5 | GO:0000791 | |
| GeneOntologyCellularComponent | actin filament bundle | 9.21e-05 | 118 | 129 | 6 | GO:0032432 | |
| GeneOntologyCellularComponent | interstitial matrix | 1.47e-04 | 17 | 129 | 3 | GO:0005614 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.42e-04 | 20 | 129 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | myofibril | 2.98e-04 | 273 | 129 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.46e-04 | 290 | 129 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | myosin filament | 4.78e-04 | 25 | 129 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 5.32e-04 | 107 | 129 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 5.32e-04 | 107 | 129 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | microtubule organizing center | ABCA2 SLF1 NUBP1 CCT4 SPAG9 ARMC9 TPGS2 BICD1 TBCCD1 NSFL1C PAFAH1B1 ASPM HERC2 WDR13 USH2A | 5.51e-04 | 919 | 129 | 15 | GO:0005815 |
| GeneOntologyCellularComponent | myosin II complex | 6.72e-04 | 28 | 129 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | actomyosin | 7.99e-04 | 117 | 129 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CHMP4C FLNA MAP2 CAPN6 EVPL CCT4 TPGS2 BICD1 AFAP1 PAFAH1B1 ASPM NAV3 AK1 DNAH5 | 1.33e-03 | 899 | 129 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | T-tubule | 1.45e-03 | 79 | 129 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.48e-03 | 349 | 129 | 8 | GO:0031965 | |
| GeneOntologyCellularComponent | microtubule | 1.75e-03 | 533 | 129 | 10 | GO:0005874 | |
| GeneOntologyCellularComponent | nuclear envelope | AKAP6 CHMP4C TEX2 ITSN1 RGPD1 PAFAH1B1 NAV3 TMPO MTDH NUP153 | 2.51e-03 | 560 | 129 | 10 | GO:0005635 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 2.64e-03 | 223 | 129 | 6 | GO:0098862 | |
| Domain | H15 | 4.88e-15 | 13 | 128 | 8 | SM00526 | |
| Domain | Linker_histone | 4.88e-15 | 13 | 128 | 8 | PF00538 | |
| Domain | H15 | 4.88e-15 | 13 | 128 | 8 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 1.13e-14 | 14 | 128 | 8 | IPR005818 | |
| Domain | Histone_H5 | 2.55e-12 | 8 | 128 | 6 | IPR005819 | |
| Domain | - | 3.14e-07 | 218 | 128 | 11 | 1.10.10.10 | |
| Domain | WHTH_DNA-bd_dom | 8.84e-07 | 242 | 128 | 11 | IPR011991 | |
| Domain | P-loop_NTPase | MYH2 MYH6 ABCA2 DRG2 MYH7B PEX1 ABCC5 NUBP1 GTPBP10 BLM DDX46 MDN1 ADSS2 ASPM NAV3 NAV2 HS3ST6 AK1 DNAH5 ADSS1 | 1.28e-06 | 848 | 128 | 20 | IPR027417 |
| Domain | AAA | 6.74e-06 | 144 | 128 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 6.74e-06 | 144 | 128 | 8 | IPR003593 | |
| Domain | Myosin-like_IQ_dom | 7.53e-06 | 19 | 128 | 4 | IPR027401 | |
| Domain | - | 7.53e-06 | 19 | 128 | 4 | 4.10.270.10 | |
| Domain | Adenylsucc_synt | 4.66e-05 | 2 | 128 | 2 | SM00788 | |
| Domain | ADENYLOSUCCIN_SYN_2 | 4.66e-05 | 2 | 128 | 2 | PS00513 | |
| Domain | Adenylosuccin_syn_GTP-bd | 4.66e-05 | 2 | 128 | 2 | IPR018220 | |
| Domain | Adenylsucc_synt | 4.66e-05 | 2 | 128 | 2 | PF00709 | |
| Domain | Adenylosuccin_syn_Lys_AS | 4.66e-05 | 2 | 128 | 2 | IPR033128 | |
| Domain | Adenylosuccinate_synthetase | 4.66e-05 | 2 | 128 | 2 | IPR001114 | |
| Domain | ADENYLOSUCCIN_SYN_1 | 4.66e-05 | 2 | 128 | 2 | PS01266 | |
| Domain | CH | 8.31e-05 | 65 | 128 | 5 | SM00033 | |
| Domain | CH | 1.18e-04 | 70 | 128 | 5 | PF00307 | |
| Domain | - | 1.27e-04 | 71 | 128 | 5 | 1.10.418.10 | |
| Domain | Myosin_N | 1.35e-04 | 15 | 128 | 3 | PF02736 | |
| Domain | Myosin_N | 1.35e-04 | 15 | 128 | 3 | IPR004009 | |
| Domain | CH | 1.45e-04 | 73 | 128 | 5 | PS50021 | |
| Domain | CH-domain | 1.64e-04 | 75 | 128 | 5 | IPR001715 | |
| Domain | Myosin_tail_1 | 2.38e-04 | 18 | 128 | 3 | PF01576 | |
| Domain | Myosin_tail | 2.38e-04 | 18 | 128 | 3 | IPR002928 | |
| Domain | - | ABCA2 DRG2 PEX1 ABCC5 NUBP1 GTPBP10 BLM DDX46 MDN1 NAV3 NAV2 HS3ST6 AK1 DNAH5 | 6.01e-04 | 746 | 128 | 14 | 3.40.50.300 |
| Domain | G_OBG | 6.87e-04 | 6 | 128 | 2 | IPR031167 | |
| Domain | G_OBG | 6.87e-04 | 6 | 128 | 2 | PS51710 | |
| Domain | LisH | 9.09e-04 | 28 | 128 | 3 | IPR006594 | |
| Domain | LisH | 9.09e-04 | 28 | 128 | 3 | SM00667 | |
| Domain | LISH | 9.09e-04 | 28 | 128 | 3 | PS50896 | |
| Domain | zf-C2H2_11 | 1.63e-03 | 9 | 128 | 2 | PF16622 | |
| Domain | IG_FLMN | 2.02e-03 | 10 | 128 | 2 | SM00557 | |
| Domain | Myosin_head_motor_dom | 2.23e-03 | 38 | 128 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.23e-03 | 38 | 128 | 3 | PS51456 | |
| Domain | LAM_G_DOMAIN | 2.23e-03 | 38 | 128 | 3 | PS50025 | |
| Domain | Myosin_head | 2.23e-03 | 38 | 128 | 3 | PF00063 | |
| Domain | MYSc | 2.23e-03 | 38 | 128 | 3 | SM00242 | |
| Domain | IQ | 2.33e-03 | 81 | 128 | 4 | SM00015 | |
| Domain | Filamin | 2.46e-03 | 11 | 128 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.46e-03 | 11 | 128 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.46e-03 | 11 | 128 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.46e-03 | 11 | 128 | 2 | IPR017868 | |
| Domain | Laminin_G_2 | 2.58e-03 | 40 | 128 | 3 | PF02210 | |
| Domain | LamG | 3.39e-03 | 44 | 128 | 3 | SM00282 | |
| Domain | IQ_motif_EF-hand-BS | 3.41e-03 | 90 | 128 | 4 | IPR000048 | |
| Domain | IQ | 3.84e-03 | 93 | 128 | 4 | PS50096 | |
| Domain | ATPase_dyneun-rel_AAA | 4.02e-03 | 14 | 128 | 2 | IPR011704 | |
| Domain | AAA_5 | 4.02e-03 | 14 | 128 | 2 | PF07728 | |
| Domain | - | 4.14e-03 | 95 | 128 | 4 | 2.60.120.200 | |
| Domain | AT_hook | 5.25e-03 | 16 | 128 | 2 | PF02178 | |
| Domain | MMR_HSR1 | 5.93e-03 | 17 | 128 | 2 | PF01926 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 1.38e-08 | 13 | 93 | 5 | M1018 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 6.52e-08 | 17 | 93 | 5 | M27189 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 8.44e-07 | 12 | 93 | 4 | MM14554 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 2.29e-06 | 15 | 93 | 4 | MM14902 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 2.28e-05 | 52 | 93 | 5 | M2341 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 7.95e-05 | 35 | 93 | 4 | M16801 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 1.72e-04 | 79 | 93 | 5 | M27191 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 3.00e-04 | 49 | 93 | 4 | MM15448 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 3.49e-04 | 142 | 93 | 6 | MM15178 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 4.36e-04 | 54 | 93 | 4 | MM14904 | |
| Pubmed | FLNA MYH2 FLNB MYH6 MYLK MYH7B ITSN1 ASH1L RGPD1 ABCC5 CCT4 HNRNPC HP1BP3 CDCA2 MDN1 AHNAK H1-2 H1-3 H1-4 ASPM H1-5 NAV2 TMPO AK1 ZFR H1-1 MPHOSPH10 ATP1A2 MTDH THRAP3 SLC6A14 | 1.63e-15 | 1442 | 130 | 31 | 35575683 | |
| Pubmed | Characterization of phosphorylation sites on histone H1 isoforms by tandem mass spectrometry. | 2.43e-15 | 6 | 130 | 6 | 15595731 | |
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 2.82e-15 | 11 | 130 | 7 | 26689747 | |
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 6.75e-15 | 12 | 130 | 7 | 22650316 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CUL1 H1-10 SLF1 CEBPG TCOF1 MTF2 GPATCH1 HNRNPC CASZ1 HP1BP3 BLM CDCA2 ATXN7L3 DDX46 MDN1 MORF4L2 AHNAK H1-2 H1-4 RBM14 H1-5 TMPO ZFR CDC5L MTDH THRAP3 NUP153 | 2.96e-13 | 1294 | 130 | 27 | 30804502 |
| Pubmed | Dynamic changes in H1 subtype composition during epigenetic reprogramming. | 5.04e-13 | 10 | 130 | 6 | 28794128 | |
| Pubmed | H1-10 FLNA FLNB TCOF1 NARS1 SPAG9 HP1BP3 BLM DDX46 MDN1 AHNAK H1-3 H1-4 ALDH18A1 ZFR H1-1 MPHOSPH10 HERC2 FSCN1 NUP153 | 5.43e-13 | 653 | 130 | 20 | 22586326 | |
| Pubmed | Expression of murine H1 histone genes during postnatal development. | 6.75e-13 | 5 | 130 | 5 | 9655912 | |
| Pubmed | The mouse histone H1 genes: gene organization and differential regulation. | 6.75e-13 | 5 | 130 | 5 | 9300059 | |
| Pubmed | 6.75e-13 | 5 | 130 | 5 | 11467742 | ||
| Pubmed | A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences. | 6.75e-13 | 5 | 130 | 5 | 8003976 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CUL1 H1-10 FLNA FLNB NARS1 CCT4 HNRNPC BLM CDCA2 MDN1 ADSS2 NSFL1C AHNAK PAFAH1B1 H1-2 RBM14 ASPM H1-5 ALDH18A1 ZFR H1-1 HERC2 CDC5L FSCN1 WDR13 THRAP3 AHNAK2 | 8.39e-13 | 1353 | 130 | 27 | 29467282 |
| Pubmed | H1-10 FLNA TCOF1 CCT4 HNRNPC HP1BP3 ZNF592 MORF4L2 H1-2 H1-3 H1-4 RBM14 TMPO ZFR CDC5L FSCN1 NUP153 | 9.16e-13 | 441 | 130 | 17 | 31239290 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | H1-10 FLNA DRG2 TCOF1 NARS1 CCT4 HNRNPC HP1BP3 DDX46 MDN1 CCDC71 NSFL1C AHNAK H1-2 H1-3 H1-4 H1-5 ALDH18A1 TMPO MPHOSPH10 LRBA CDC5L FSCN1 MTDH THRAP3 NUP153 | 3.08e-12 | 1318 | 130 | 26 | 30463901 |
| Pubmed | 4.04e-12 | 6 | 130 | 5 | 15562002 | ||
| Pubmed | Linker histone transitions during mammalian oogenesis and embryogenesis. | 4.04e-12 | 6 | 130 | 5 | 9499577 | |
| Pubmed | H1 family histones in the nucleus. Control of binding and localization by the C-terminal domain. | 4.04e-12 | 6 | 130 | 5 | 15911621 | |
| Pubmed | The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone. | 4.04e-12 | 6 | 130 | 5 | 21425800 | |
| Pubmed | Hormone-mediated dephosphorylation of specific histone H1 isoforms. | 4.04e-12 | 6 | 130 | 5 | 11479299 | |
| Pubmed | FLNA FLNB FAT3 ADARB1 HNRNPC MDN1 AHNAK ASPM TMPO LRBA CDC5L DNAH5 THRAP3 | 5.41e-12 | 234 | 130 | 13 | 36243803 | |
| Pubmed | ANKS6 TCOF1 GPATCH1 ABCC5 CCT4 SPAG9 HP1BP3 BLM CDCA2 AHNAK H1-4 ADAMTS16 RBM14 ALDH18A1 TMPO ZFR LRBA CLEC16A MTDH THRAP3 | 1.26e-11 | 777 | 130 | 20 | 35844135 | |
| Pubmed | All known human H1 histone genes except the H1(0) gene are clustered on chromosome 6. | 1.41e-11 | 7 | 130 | 5 | 8325638 | |
| Pubmed | 1.89e-11 | 16 | 130 | 6 | 33288900 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CUL1 H1-10 FLNA FLNB ABCA2 ASH1L CCT4 HNRNPC HP1BP3 MDN1 ADSS2 AHNAK H1-2 H1-3 H1-4 RBM14 H1-5 ALDH18A1 LRBA AHNAK2 | 2.48e-11 | 807 | 130 | 20 | 30575818 |
| Pubmed | High-throughput kinase assays with protein substrates using fluorescent polymer superquenching. | 1.68e-10 | 10 | 130 | 5 | 15927069 | |
| Pubmed | 1.86e-10 | 4 | 130 | 4 | 19072710 | ||
| Pubmed | 1.86e-10 | 4 | 130 | 4 | 11746507 | ||
| Pubmed | 1.86e-10 | 4 | 130 | 4 | 10997781 | ||
| Pubmed | FLNA MYH2 FLNB MYH7B H1-3 H1-4 H1-5 TMPO MPHOSPH10 HERC2 CDC5L NUP153 | 1.99e-10 | 250 | 130 | 12 | 33536335 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | H1-10 FLNA FLNB NARS1 EVPL CCT4 HNRNPC HP1BP3 AFAP1 AHNAK H1-3 RBM14 H1-5 ALDH18A1 TMPO ZFR MPHOSPH10 CDC5L FSCN1 LSM14B MTDH THRAP3 NUP153 | 2.84e-10 | 1257 | 130 | 23 | 36526897 |
| Pubmed | H1-10 FLNA SLF1 TCOF1 PEX1 CCT4 HNRNPC HP1BP3 DDX46 MORF4L2 H1-2 H1-3 H1-4 RBM14 ALDH18A1 ZFR H1-1 CDC5L ATP1A2 LSM14B THRAP3 NUP153 | 3.35e-10 | 1153 | 130 | 22 | 29845934 | |
| Pubmed | H1-10 FLNA FLNB TCOF1 EVPL HNRNPC HP1BP3 BLM AHNAK H1-2 H1-4 RBM14 H1-5 ALDH18A1 TMPO CDC5L THRAP3 | 4.06e-10 | 652 | 130 | 17 | 31180492 | |
| Pubmed | H1-10 FLNB TCOF1 EVPL CCT4 HNRNPC HP1BP3 DDX46 MDN1 ZNF592 H1-4 RBM14 ALDH18A1 ZFR MPHOSPH10 CDC5L MTDH THRAP3 NUP153 | 4.33e-10 | 847 | 130 | 19 | 35850772 | |
| Pubmed | CUL1 H1-10 FLNA TCOF1 HNRNPC HP1BP3 DDX46 H1-2 H1-3 H1-4 RBM14 H1-5 TMPO ZFR CDC5L THRAP3 NUP153 | 4.35e-10 | 655 | 130 | 17 | 35819319 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H1-10 FLNA SLF1 POLH GPATCH1 HNRNPC HP1BP3 BLM CDCA2 DDX46 AHNAK H1-2 RBM14 TMPO ZFR MPHOSPH10 CDC5L MTDH THRAP3 NUP153 | 4.65e-10 | 954 | 130 | 20 | 36373674 |
| Pubmed | FLNA FLNB HNRNPC HP1BP3 DDX46 AFAP1 AHNAK H1-2 H1-3 H1-4 RBM14 H1-5 ALDH18A1 TMPO ZFR CDC5L THRAP3 | 4.89e-10 | 660 | 130 | 17 | 32780723 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | FLNA TCOF1 POLH RGPD1 ADARB1 BLM DDX46 AHNAK RBM14 TMPO ZFR NUP153 | 5.01e-10 | 271 | 130 | 12 | 32433965 |
| Pubmed | FLNA FLNB DRG2 TCOF1 MYH7B HIKESHI CCT4 SPAG9 HNRNPC ADSS2 H1-2 H1-3 H1-4 H1-5 ALDH18A1 H1-1 LRBA ATP1A2 FSCN1 | 7.85e-10 | 878 | 130 | 19 | 37223481 | |
| Pubmed | 8.48e-10 | 13 | 130 | 5 | 8858344 | ||
| Pubmed | Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. | 9.29e-10 | 5 | 130 | 4 | 10893414 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | H1-10 FLNA FLNB TCOF1 MRPL27 ADARB1 HNRNPC DDX46 H1-2 H1-3 H1-4 RBM14 ZFR MPHOSPH10 CDC5L LSM14B MTDH THRAP3 | 1.42e-09 | 807 | 130 | 18 | 22681889 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | FLNA MYH2 FLNB TCOF1 ITSN1 CCT4 HNRNPC CASZ1 AHNAK H1-2 H1-4 RBM14 H1-5 TMPO HERC2 THRAP3 | 1.83e-09 | 626 | 130 | 16 | 33644029 |
| Pubmed | CUL1 TEX2 HNRNPC HP1BP3 DDX46 H1-2 RBM14 TMPO ZFR CDC5L THRAP3 | 2.26e-09 | 244 | 130 | 11 | 29884807 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | CUL1 H1-10 FLNA FLNB TCOF1 CCT4 HNRNPC HP1BP3 DDX46 AHNAK H1-2 H1-3 H1-4 RBM14 H1-5 ZFR MPHOSPH10 CDC5L THRAP3 | 2.80e-09 | 949 | 130 | 19 | 36574265 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | H1-10 GTPBP10 HP1BP3 BLM CDCA2 DDX46 MDN1 MORF4L2 H1-4 RBM14 ASPM TMPO ZFR MPHOSPH10 HERC2 CDC5L MTDH | 3.97e-09 | 759 | 130 | 17 | 35915203 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FOXM1 H1-10 FLNA TCOF1 ITSN1 SPAG9 ADARB1 HNRNPC BLM DDX46 MDN1 NSFL1C ZNF592 RBM14 TMPO THRAP3 NUP153 | 5.31e-09 | 774 | 130 | 17 | 15302935 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNA FLNB TCOF1 CCT4 HNRNPC BLM CDCA2 MDN1 ZNF592 AHNAK H1-2 RBM14 ALDH18A1 TMPO ZFR MPHOSPH10 CDC5L THRAP3 NUP153 | 5.47e-09 | 989 | 130 | 19 | 36424410 |
| Pubmed | 6.47e-09 | 7 | 130 | 4 | 24435047 | ||
| Pubmed | FLNB VPS39 HP1BP3 MORF4L2 AHNAK H1-2 H1-3 H1-4 RBM14 H1-5 ALDH18A1 TMPO MPHOSPH10 THRAP3 | 6.93e-09 | 503 | 130 | 14 | 36217030 | |
| Pubmed | H1-10 FLNA FLNB TCOF1 PEX1 CCT4 DDX46 H1-4 ASPM TMPO ZFR CDC5L THRAP3 NUP153 | 7.47e-09 | 506 | 130 | 14 | 30890647 | |
| Pubmed | CUL1 NARS1 CCT4 HP1BP3 BLM DDX46 MDN1 ADSS2 ZNF592 AHNAK H1-2 RBM14 H1-5 AK1 ZFR CDC5L FSCN1 THRAP3 NUP153 | 8.17e-09 | 1014 | 130 | 19 | 32416067 | |
| Pubmed | 9.54e-09 | 159 | 130 | 9 | 34537242 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | H1-10 FLNA FLNB TCOF1 CCT4 HNRNPC HP1BP3 DDX46 MDN1 AHNAK H1-4 RBM14 TMPO ZFR HERC2 CDC5L MTDH THRAP3 NUP153 | 9.56e-09 | 1024 | 130 | 19 | 24711643 |
| Pubmed | CUL1 H1-10 FLNA TCOF1 CCT4 HNRNPC HP1BP3 MDN1 ZNF592 AHNAK H1-2 H1-3 ALDH18A1 TMPO CDC5L MTDH NUP153 | 1.02e-08 | 809 | 130 | 17 | 32129710 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | H1-10 FLNA FLNB TCOF1 NARS1 CCT4 SPAG9 HNRNPC DDX46 MDN1 NSFL1C AHNAK PAFAH1B1 H1-2 RBM14 TMPO CDC5L FSCN1 LSM14B NUP153 | 1.09e-08 | 1149 | 130 | 20 | 35446349 |
| Pubmed | H1-10 FLNA FLNB MYLK NARS1 CCT4 HNRNPC DDX46 H1-2 ZNF667 H1-4 RBM14 TMPO ZFR MTDH THRAP3 | 1.10e-08 | 711 | 130 | 16 | 33022573 | |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | H1-10 FLNA CCT4 HP1BP3 MORF4L2 H1-2 H1-3 H1-4 RBM14 ALDH18A1 TMPO | 1.22e-08 | 287 | 130 | 11 | 36180891 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | H1-10 FLNA FLNB TCOF1 NARS1 NUBP1 CCT4 GTPBP10 HNRNPC HP1BP3 DDX46 MORF4L2 AHNAK H1-2 RBM14 H1-5 ALDH18A1 CDC5L FSCN1 MTDH THRAP3 AHNAK2 | 1.41e-08 | 1415 | 130 | 22 | 28515276 |
| Pubmed | FLNA FLNB TCOF1 HNRNPC HP1BP3 H1-3 H1-4 RBM14 TMPO CDC5L AHNAK2 | 1.61e-08 | 295 | 130 | 11 | 26209609 | |
| Pubmed | H1-10 TCOF1 CCT4 HNRNPC HP1BP3 DDX46 H1-2 H1-3 H1-4 RBM14 TMPO ZFR CDC5L LSM14B MTDH THRAP3 | 1.62e-08 | 731 | 130 | 16 | 29298432 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.83e-08 | 231 | 130 | 10 | 16452087 | |
| Pubmed | CUL1 FLNA MYH2 FLNB NARS1 CCT4 MUC13 GTPBP10 DDX46 AFAP1 MDN1 ADSS2 AHNAK RBM14 H1-5 ALDH18A1 TMPO ZFR CDC5L MTDH THRAP3 AHNAK2 | 1.93e-08 | 1440 | 130 | 22 | 30833792 | |
| Pubmed | 1.94e-08 | 121 | 130 | 8 | 22412018 | ||
| Pubmed | H1-10 TCOF1 CCT4 HNRNPC DDX46 H1-2 H1-4 RBM14 ALDH18A1 TMPO ZFR FSCN1 MTDH THRAP3 NUP153 | 1.96e-08 | 641 | 130 | 15 | 36057605 | |
| Pubmed | H1-10 FLNA FLNB CCT4 HNRNPC H1-3 RBM14 ALDH18A1 TMPO ZFR CDC5L LSM14B MTDH THRAP3 | 2.17e-08 | 551 | 130 | 14 | 34728620 | |
| Pubmed | CUL1 H1-10 FLNA FLNB TCOF1 MRPL27 CCT4 GTPBP10 HNRNPC MORF4L2 RBM14 ASPM TMPO ZFR CDC5L LSM14B MTDH NUP153 | 2.47e-08 | 971 | 130 | 18 | 33306668 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | FLNB DRG2 TCOF1 RGPD1 NARS1 CCT4 HNRNPC HP1BP3 DDX46 RBM14 TMPO AK1 ZFR ATP1A2 THRAP3 | 3.18e-08 | 665 | 130 | 15 | 30457570 |
| Pubmed | 4.28e-08 | 88 | 130 | 7 | 26318153 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.81e-08 | 256 | 130 | 10 | 33397691 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 26209608 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 2613692 | ||
| Pubmed | High-resolution mapping of h1 linker histone variants in embryonic stem cells. | 5.10e-08 | 3 | 130 | 3 | 23633960 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 24525734 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 21245380 | ||
| Pubmed | 5.37e-08 | 259 | 130 | 10 | 31162944 | ||
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 5.41e-08 | 54 | 130 | 6 | 25631074 | |
| Pubmed | 5.72e-08 | 334 | 130 | 11 | 30425250 | ||
| Pubmed | CUL1 FLNA TCOF1 BLM DDX46 MORF4L2 AHNAK RBM14 TMPO ZFR CDC5L | 6.85e-08 | 340 | 130 | 11 | 24332808 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | H1-10 TCOF1 HNRNPC HP1BP3 DDX46 MDN1 ZNF592 H1-2 RBM14 TMPO ZFR CDC5L MTDH THRAP3 | 6.88e-08 | 605 | 130 | 14 | 28977666 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 7.39e-08 | 268 | 130 | 10 | 33024031 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA TCOF1 GPATCH1 CCT4 SPAG9 HP1BP3 DDX46 AHNAK ZNF667 H1-4 TMPO ZFR LRBA CDC5L MTDH NUP153 AHNAK2 | 8.11e-08 | 934 | 130 | 17 | 33916271 |
| Pubmed | FLNA FLNB MYH6 MAP2 ITSN1 NARS1 CCT4 HNRNPC HP1BP3 AFAP1 TENM4 MORF4L2 PAFAH1B1 H1-3 RBM14 TMPO CDC5L ATP1A2 FSCN1 MTDH THRAP3 | 8.31e-08 | 1431 | 130 | 21 | 37142655 | |
| Pubmed | FLNA MYH2 FLNB MYH6 RGPD1 NARS1 CCT4 HNRNPC AHNAK H1-2 H1-3 H1-4 RBM14 H1-1 FSCN1 THRAP3 | 1.16e-07 | 844 | 130 | 16 | 25963833 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | H1-10 FLNA TCOF1 MRPL27 HNRNPC CASZ1 HP1BP3 BLM NSFL1C MORF4L2 AHNAK PAFAH1B1 H1-2 CCSER2 TMPO H1-1 MTDH THRAP3 ZNF239 | 1.20e-07 | 1203 | 130 | 19 | 29180619 |
| Pubmed | FLNA FLNB TCOF1 EVPL AHNAK ALDH18A1 TMPO ZFR CDC5L FSCN1 AHNAK2 | 1.22e-07 | 360 | 130 | 11 | 33111431 | |
| Pubmed | 1.29e-07 | 215 | 130 | 9 | 35973513 | ||
| Pubmed | 1.34e-07 | 216 | 130 | 9 | 37640791 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.49e-07 | 289 | 130 | 10 | 23752268 | |
| Pubmed | FOXM1 FLNA PLB1 TCOF1 VPS39 TEX2 PEX1 MUC13 H1-8 H1-3 H1-5 ZFR MPHOSPH10 FSCN1 MTDH | 1.61e-07 | 754 | 130 | 15 | 35906200 | |
| Pubmed | 1.62e-07 | 159 | 130 | 8 | 22751105 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 1.62e-07 | 221 | 130 | 9 | 29991511 | |
| Pubmed | H1 linker histones are essential for mouse development and affect nucleosome spacing in vivo. | 2.04e-07 | 4 | 130 | 3 | 12808097 | |
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 11689686 | ||
| Pubmed | Isolation of two murine H1 histone genes and chromosomal mapping of the H1 gene complement. | 2.04e-07 | 4 | 130 | 3 | 8589518 | |
| Pubmed | 2.46e-07 | 15 | 130 | 4 | 28784777 | ||
| Pubmed | FLNA FLNB MAP2 TEX2 RGPD1 CCT4 AMER2 TENM4 NSFL1C H1-2 H1-4 H1-5 NAV3 AK1 ATP1A2 CLEC16A MTDH THRAP3 | 2.65e-07 | 1139 | 130 | 18 | 36417873 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 2.73e-07 | 235 | 130 | 9 | 28378594 | |
| Pubmed | AKAP6 FLNB ABCA2 ZBTB38 TCOF1 VPS39 ITSN1 ASH1L NARS1 ABCC5 ADARB1 BICD1 ZNF592 MORF4L2 NAV3 LRBA HERC2 ATP1A2 WDR13 | 3.29e-07 | 1285 | 130 | 19 | 35914814 | |
| Pubmed | H1-10 TCOF1 HNRNPC H1-2 H1-4 RBM14 H1-5 ALDH18A1 MTDH THRAP3 | 3.49e-07 | 317 | 130 | 10 | 30997501 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CUL1 H1-10 FLNA FLNB TCOF1 CCT4 HNRNPC CDCA2 MDN1 ADSS2 H1-2 RBM14 ALDH18A1 TMPO ZFR CDC5L DNAH5 MTDH THRAP3 NUP153 | 3.55e-07 | 1425 | 130 | 20 | 30948266 |
| Interaction | ECT2 interactions | FOXM1 H1-10 FLNA FLNB TCOF1 CCT4 SPAG9 N4BP3 HNRNPC BLM DDX46 AFAP1 AHNAK H1-3 H1-4 RBM14 ASPM H1-5 NAV3 TMPO H1-1 CDC5L THRAP3 AHNAK2 | 1.87e-09 | 887 | 129 | 24 | int:ECT2 |
| Interaction | KIF20A interactions | FLNA FLNB ZBTB38 POLH SPAG9 N4BP3 HNRNPC RGS12 BLM DDX46 AFAP1 AHNAK H1-2 H1-3 H1-4 RBM14 TXNRD3 H1-5 NAV3 NAV2 TMPO H1-1 HERC2 WDR13 THRAP3 AHNAK2 | 2.39e-09 | 1052 | 129 | 26 | int:KIF20A |
| Interaction | H2BC9 interactions | H1-10 MYH2 ASH1L SPAG9 ADARB1 CDCA2 H1-8 AHNAK SETBP1 H1-2 H1-3 H1-4 H1-5 TMPO H1-1 FSCN1 DNAH5 | 3.95e-09 | 446 | 129 | 17 | int:H2BC9 |
| Interaction | SIRT7 interactions | H1-10 FLNA FLNB TCOF1 POLH NARS1 SPAG9 HP1BP3 BLM DDX46 MDN1 AHNAK H1-3 H1-4 ALDH18A1 ZFR H1-1 MPHOSPH10 HERC2 FSCN1 NUP153 | 1.06e-08 | 744 | 129 | 21 | int:SIRT7 |
| Interaction | FXR1 interactions | FOXM1 CHMP4C CUL1 FLNA FLNB ZBTB38 TCOF1 MYH7B ITSN1 N4BP3 BICD1 H1-2 H1-4 H1-5 TMPO HERC2 CDC5L MTDH THRAP3 NUP153 | 1.22e-08 | 679 | 129 | 20 | int:FXR1 |
| Interaction | ADARB1 interactions | FLNA TCOF1 POLH RGPD1 GTPBP10 ADARB1 HNRNPC HP1BP3 BLM DDX46 AHNAK RBM14 TMPO ZFR H1-1 MPHOSPH10 NUP153 | 1.54e-08 | 489 | 129 | 17 | int:ADARB1 |
| Interaction | H2AC13 interactions | 2.67e-08 | 75 | 129 | 8 | int:H2AC13 | |
| Interaction | CIT interactions | H1-10 FLNA FLNB TCOF1 ASH1L NARS1 CCT4 HNRNPC HP1BP3 BICD1 DDX46 MORF4L2 AHNAK H1-2 H1-3 H1-4 RBM14 H1-5 FGF2 ALDH18A1 TMPO ZFR MPHOSPH10 CDC5L FSCN1 MTDH THRAP3 NUP153 AHNAK2 | 2.87e-08 | 1450 | 129 | 29 | int:CIT |
| Interaction | GLE1 interactions | 4.45e-08 | 150 | 129 | 10 | int:GLE1 | |
| Interaction | H3-3A interactions | POLH ASH1L SPAG9 HNRNPC CASZ1 HP1BP3 BLM CDCA2 CCDC71 ZNF592 MORF4L2 H1-2 H1-3 H1-4 H1-5 FGF2 TMPO H1-1 HERC2 THRAP3 | 6.16e-08 | 749 | 129 | 20 | int:H3-3A |
| Interaction | H2AC12 interactions | 6.76e-08 | 118 | 129 | 9 | int:H2AC12 | |
| Interaction | H2AC11 interactions | CUL1 H1-10 ADARB1 H1-8 ADSS2 AHNAK H1-2 H1-3 H1-4 H1-5 H1-1 AHNAK2 | 6.78e-08 | 248 | 129 | 12 | int:H2AC11 |
| Interaction | RSL1D1 interactions | CHMP4C CUL1 H1-10 DRG2 ADARB1 HP1BP3 H1-8 H1-2 H1-3 H1-4 RBM14 H1-5 H1-1 MPHOSPH10 FSCN1 MTDH | 7.32e-08 | 479 | 129 | 16 | int:RSL1D1 |
| Interaction | FTSJ3 interactions | CHMP4C CUL1 NARS1 ADARB1 HP1BP3 H1-8 H1-2 H1-3 H1-4 RBM14 H1-5 H1-1 MPHOSPH10 CDC5L MTDH | 8.65e-08 | 422 | 129 | 15 | int:FTSJ3 |
| Interaction | NUP43 interactions | H1-10 FLNA POLH GPATCH1 ASH1L HP1BP3 BLM CDCA2 ZNF592 H1-2 CCSER2 H1-4 RBM14 H1-1 MPHOSPH10 FSCN1 NUP153 AHNAK2 | 9.87e-08 | 625 | 129 | 18 | int:NUP43 |
| Interaction | CDK2 interactions | FOXM1 CUL1 FLNA FLNB CEBPG TCOF1 VPS39 MRPL27 CCT4 HNRNPC AFAP1 AHNAK PAFAH1B1 H1-2 H1-3 H1-5 ALDH18A1 H1-1 CDC5L FSCN1 | 1.26e-07 | 783 | 129 | 20 | int:CDK2 |
| Interaction | RPS19 interactions | CHMP4C CUL1 H1-10 ASH1L MRPL27 HNRNPC HP1BP3 BLM H1-2 H1-3 H1-4 H1-5 FGF2 ZFR H1-1 MPHOSPH10 HERC2 THRAP3 | 1.37e-07 | 639 | 129 | 18 | int:RPS19 |
| Interaction | TAAR3P interactions | 1.97e-07 | 9 | 129 | 4 | int:TAAR3P | |
| Interaction | RPA4 interactions | FLNA TCOF1 GPATCH1 HNRNPC BLM MDN1 ADSS2 NSFL1C AHNAK H1-2 H1-4 TMPO CDC5L THRAP3 NUP153 | 2.10e-07 | 452 | 129 | 15 | int:RPA4 |
| Interaction | NSD2 interactions | FLNA TCOF1 ADARB1 HP1BP3 DDX46 CCDC71 H1-2 H1-4 H1-5 TMPO H1-1 THRAP3 | 2.34e-07 | 278 | 129 | 12 | int:NSD2 |
| Interaction | NLE1 interactions | FLNA DRG2 TCOF1 GPATCH1 CCT4 ADARB1 BLM MDN1 RBM14 TMPO MPHOSPH10 | 2.52e-07 | 228 | 129 | 11 | int:NLE1 |
| Interaction | H1-6 interactions | MRPL27 HP1BP3 H1-8 AFAP1 SETBP1 H1-2 H1-3 H1-4 H1-5 H1-1 MPHOSPH10 | 2.63e-07 | 229 | 129 | 11 | int:H1-6 |
| Interaction | RRS1 interactions | CHMP4C ADARB1 HNRNPC HP1BP3 H1-8 H1-2 CMA1 H1-3 H1-4 RBM14 H1-1 MPHOSPH10 MTDH | 3.42e-07 | 345 | 129 | 13 | int:RRS1 |
| Interaction | SMC5 interactions | H1-10 FLNA SLF1 POLH GPATCH1 HNRNPC HP1BP3 BLM CDCA2 DDX46 AHNAK H1-2 RBM14 H1-5 TMPO ZFR H1-1 MPHOSPH10 CDC5L MTDH THRAP3 NUP153 | 3.65e-07 | 1000 | 129 | 22 | int:SMC5 |
| Interaction | EED interactions | CUL1 H1-10 FLNA FLNB DRG2 TCOF1 MTF2 VPS39 CAPN6 PEX1 CCT4 HNRNPC CASZ1 HP1BP3 USP21 CCDC71 H1-2 H1-4 RBM14 ALDH18A1 TMPO ZFR H1-1 HERC2 CDC5L FSCN1 THRAP3 | 3.73e-07 | 1445 | 129 | 27 | int:EED |
| Interaction | ACTC1 interactions | H1-10 FLNA FLNB MYLK TCOF1 PEX1 CCT4 ADARB1 DDX46 AFAP1 H1-4 ASPM TMPO ZFR CDC5L FSCN1 THRAP3 NUP153 | 4.61e-07 | 694 | 129 | 18 | int:ACTC1 |
| Interaction | NOP2 interactions | CHMP4C CUL1 ASH1L GTPBP10 ADARB1 HP1BP3 H1-8 H1-2 H1-4 H1-5 H1-1 MPHOSPH10 CDC5L MTDH | 4.63e-07 | 416 | 129 | 14 | int:NOP2 |
| Interaction | H2BC21 interactions | CUL1 H1-10 MTF2 GTPBP10 ADARB1 HP1BP3 BLM ATXN7L3 CCDC71 MORF4L2 AHNAK H1-2 H1-3 H1-4 H1-5 H1-1 FSCN1 DNAH5 | 4.81e-07 | 696 | 129 | 18 | int:H2BC21 |
| Interaction | USP14 interactions | FLNA FLNB NARS1 CCT4 HP1BP3 USP21 NSFL1C AHNAK H1-2 H1-3 H1-4 RBM14 TMPO MTDH AHNAK2 | 5.70e-07 | 489 | 129 | 15 | int:USP14 |
| Interaction | H3-5 interactions | 7.06e-07 | 114 | 129 | 8 | int:H3-5 | |
| Interaction | NR2C2 interactions | H1-10 FLNA DRG2 TCOF1 NARS1 CCT4 HNRNPC HP1BP3 DDX46 MDN1 CCDC71 NSFL1C AHNAK H1-2 H1-3 H1-4 H1-5 ALDH18A1 TMPO MPHOSPH10 LRBA CDC5L FSCN1 MTDH THRAP3 NUP153 | 7.49e-07 | 1403 | 129 | 26 | int:NR2C2 |
| Interaction | H2AC4 interactions | CUL1 H1-10 POLH MRPL27 HNRNPC HP1BP3 BLM MDN1 H1-2 H1-3 H1-4 H1-5 ZFR H1-1 DNAH5 | 8.75e-07 | 506 | 129 | 15 | int:H2AC4 |
| Interaction | CHMP4B interactions | CHMP4C H1-10 FLNA FLNB TCOF1 HNRNPC DDX46 AFAP1 AHNAK H1-3 H1-4 RBM14 H1-5 ALDH18A1 TMPO HERC2 THRAP3 AHNAK2 | 9.01e-07 | 727 | 129 | 18 | int:CHMP4B |
| Interaction | SLFN11 interactions | FLNA MYH2 FLNB MYH7B CCT4 H1-3 H1-4 H1-5 TMPO MPHOSPH10 HERC2 CDC5L NUP153 | 9.03e-07 | 376 | 129 | 13 | int:SLFN11 |
| Interaction | OBSL1 interactions | H1-10 FLNA FLNB MAP2 TCOF1 ECM2 HNRNPC HP1BP3 DDX46 MDN1 AHNAK H1-4 RBM14 TMPO ZFR HERC2 CDC5L CLEC16A THRAP3 NUP153 | 1.18e-06 | 902 | 129 | 20 | int:OBSL1 |
| Interaction | H1-2 interactions | CHMP4C CUL1 H1-10 FLNA TCOF1 CAPN6 HP1BP3 BLM H1-8 AHNAK PAFAH1B1 H1-2 H1-3 H1-4 H1-5 H1-1 MPHOSPH10 | 1.23e-06 | 666 | 129 | 17 | int:H1-2 |
| Interaction | DKC1 interactions | CHMP4C TCOF1 ADARB1 HNRNPC ADSS2 H1-2 H1-3 H1-4 H1-5 H1-1 MPHOSPH10 HERC2 MTDH | 1.48e-06 | 393 | 129 | 13 | int:DKC1 |
| Interaction | NUPR1 interactions | FLNA FLNB HNRNPC HP1BP3 DDX46 AFAP1 AHNAK H1-2 H1-3 H1-4 RBM14 H1-5 ALDH18A1 TMPO ZFR CDC5L THRAP3 | 1.74e-06 | 683 | 129 | 17 | int:NUPR1 |
| Interaction | CUL7 interactions | CUL1 H1-10 FLNA FLNB TCOF1 CCT4 HNRNPC HP1BP3 DDX46 MDN1 AHNAK H1-4 RBM14 TMPO ZFR H1-1 CDC5L MTDH THRAP3 | 1.83e-06 | 845 | 129 | 19 | int:CUL7 |
| Interaction | AGR2 interactions | CUL1 H1-10 FLNA FLNB ABCA2 ASH1L CCT4 HNRNPC HP1BP3 MDN1 ADSS2 AHNAK H1-2 H1-3 H1-4 RBM14 H1-5 ALDH18A1 LRBA AHNAK2 | 2.01e-06 | 934 | 129 | 20 | int:AGR2 |
| Interaction | RNF113A interactions | CUL1 H1-10 FLNA TCOF1 HNRNPC HP1BP3 DDX46 H1-2 H1-3 H1-4 RBM14 H1-5 TMPO ZFR CDC5L THRAP3 NUP153 | 2.07e-06 | 692 | 129 | 17 | int:RNF113A |
| Interaction | CHD4 interactions | H1-10 TCOF1 MTF2 SPAG9 ADARB1 HNRNPC HP1BP3 DDX46 MDN1 ZNF592 AHNAK H1-2 H1-4 RBM14 TMPO ZFR H1-1 CDC5L MTDH THRAP3 | 2.14e-06 | 938 | 129 | 20 | int:CHD4 |
| Interaction | SPAST interactions | 2.69e-06 | 136 | 129 | 8 | int:SPAST | |
| Interaction | DHX8 interactions | FLNA GPATCH1 HNRNPC CASZ1 BLM DDX46 H1-4 H1-5 H1-1 CDC5L THRAP3 | 2.87e-06 | 292 | 129 | 11 | int:DHX8 |
| Interaction | IFI16 interactions | CHMP4C H1-10 FLNA NARS1 GTPBP10 HP1BP3 MORF4L2 H1-2 H1-3 H1-4 RBM14 ASPM FGF2 MPHOSPH10 CDC5L MTDH NUP153 | 3.15e-06 | 714 | 129 | 17 | int:IFI16 |
| Interaction | BICD2 interactions | ITSN1 GPATCH1 CAPN6 RGPD1 BICD1 PAFAH1B1 H1-2 H1-4 H1-5 H1-1 HERC2 DNAH5 NUP153 | 3.58e-06 | 426 | 129 | 13 | int:BICD2 |
| Interaction | RPL3 interactions | CHMP4C CUL1 SPAG9 GTPBP10 ADARB1 HP1BP3 H1-8 PAFAH1B1 H1-2 H1-4 H1-5 TMPO H1-1 MPHOSPH10 CDC5L MTDH AHNAK2 | 3.66e-06 | 722 | 129 | 17 | int:RPL3 |
| Interaction | SERBP1 interactions | CHMP4C CUL1 FLNA FLNB DRG2 TCOF1 MYH7B HIKESHI CCT4 SPAG9 GTPBP10 ADARB1 HNRNPC ADSS2 MORF4L2 H1-2 H1-3 H1-4 H1-5 ALDH18A1 H1-1 LRBA ATP1A2 FSCN1 MTDH | 3.71e-06 | 1432 | 129 | 25 | int:SERBP1 |
| Interaction | PRC1 interactions | FOXM1 H1-10 FLNA FLNB HNRNPC RGS12 HP1BP3 DDX46 AFAP1 AHNAK H1-2 H1-3 H1-4 RBM14 H1-5 TMPO ZFR CDC5L THRAP3 NUP153 | 3.72e-06 | 973 | 129 | 20 | int:PRC1 |
| Interaction | DOT1L interactions | H1-10 FLNB TCOF1 EVPL CCT4 HP1BP3 DDX46 MDN1 ZNF592 H1-2 H1-4 ALDH18A1 ZFR H1-1 MPHOSPH10 CDC5L THRAP3 NUP153 | 3.93e-06 | 807 | 129 | 18 | int:DOT1L |
| Interaction | H2AC14 interactions | 4.11e-06 | 144 | 129 | 8 | int:H2AC14 | |
| Interaction | IPO7 interactions | CHMP4C H1-10 ZBTB38 HP1BP3 H1-2 H1-4 ASPM H1-5 MPHOSPH10 CDC5L NUP153 | 4.22e-06 | 304 | 129 | 11 | int:IPO7 |
| Interaction | ILF3 interactions | CHMP4C CUL1 H1-10 GTPBP10 ADARB1 HNRNPC HP1BP3 H1-2 H1-3 H1-4 RBM14 ALDH18A1 TMPO ZFR H1-1 MPHOSPH10 CDC5L CLEC16A MTDH | 4.29e-06 | 896 | 129 | 19 | int:ILF3 |
| Interaction | RBBP7 interactions | FLNA ZBTB38 TCOF1 MTF2 POLH ASH1L CCT4 SPAG9 CCDC71 ADSS2 MORF4L2 CDC5L FSCN1 THRAP3 | 4.71e-06 | 507 | 129 | 14 | int:RBBP7 |
| Interaction | TSKS interactions | 5.47e-06 | 40 | 129 | 5 | int:TSKS | |
| Interaction | HEXIM1 interactions | H1-10 FLNA TCOF1 CCT4 HNRNPC HP1BP3 CCDC71 MORF4L2 H1-2 H1-3 H1-4 RBM14 ALDH18A1 ZFR H1-1 CDC5L ATP1A2 LSM14B THRAP3 | 5.62e-06 | 913 | 129 | 19 | int:HEXIM1 |
| Interaction | DCAF4 interactions | FLNA TCOF1 POLH GPATCH1 ASH1L CCT4 H1-2 CCSER2 RBM14 H1-1 MPHOSPH10 FSCN1 | 5.81e-06 | 378 | 129 | 12 | int:DCAF4 |
| Interaction | MYCN interactions | H1-10 FLNA MAP2 TCOF1 GPATCH1 MRPL27 CCT4 GTPBP10 ADARB1 HNRNPC HP1BP3 DDX46 MORF4L2 H1-2 H1-4 RBM14 H1-5 TMPO ZFR MPHOSPH10 CDC5L LSM14B MTDH THRAP3 | 5.88e-06 | 1373 | 129 | 24 | int:MYCN |
| Interaction | DCAF12 interactions | 6.10e-06 | 108 | 129 | 7 | int:DCAF12 | |
| Interaction | PCBP1 interactions | CUL1 FLNA POLH CCT4 ADARB1 HNRNPC ADSS2 AHNAK H1-2 H1-3 RBM14 TMPO HERC2 CDC5L FSCN1 THRAP3 | 6.18e-06 | 671 | 129 | 16 | int:PCBP1 |
| Interaction | WDR5 interactions | CUL1 H1-10 FLNA FLNB MYLK NARS1 CCT4 SPAG9 HNRNPC DDX46 SETBP1 PAFAH1B1 H1-2 ZNF667 H1-4 RBM14 TMPO ZFR H1-1 MTDH THRAP3 | 6.61e-06 | 1101 | 129 | 21 | int:WDR5 |
| Interaction | HDAC11 interactions | 6.76e-06 | 154 | 129 | 8 | int:HDAC11 | |
| Interaction | CHD3 interactions | H1-10 FLNA MTF2 ADARB1 HNRNPC HP1BP3 DDX46 MDN1 ZNF592 H1-2 H1-4 RBM14 TMPO ZFR CDC5L MTDH THRAP3 | 6.84e-06 | 757 | 129 | 17 | int:CHD3 |
| Interaction | ACE2 interactions | H1-10 FLNA FLNB TCOF1 CCT4 HNRNPC HP1BP3 DDX46 H1-2 CCSER2 H1-4 RBM14 H1-5 ALDH18A1 TMPO ZFR FSCN1 MTDH THRAP3 NUP153 AHNAK2 | 7.08e-06 | 1106 | 129 | 21 | int:ACE2 |
| Interaction | UTP3 interactions | 7.79e-06 | 157 | 129 | 8 | int:UTP3 | |
| Interaction | GRWD1 interactions | CHMP4C CUL1 H1-10 FLNA CCT4 HNRNPC HP1BP3 H1-2 H1-3 CDC5L MTDH THRAP3 | 7.96e-06 | 390 | 129 | 12 | int:GRWD1 |
| Interaction | CHMP4C interactions | CHMP4C FLNA FLNB CCT4 HNRNPC AHNAK H1-2 H1-3 H1-4 RBM14 H1-5 NAV2 ALDH18A1 TMPO CDC5L FSCN1 | 8.30e-06 | 687 | 129 | 16 | int:CHMP4C |
| Interaction | MYBBP1A interactions | CHMP4C CUL1 H1-10 MYH6 ZBTB38 ADARB1 HNRNPC HP1BP3 H1-4 TMPO H1-1 CDC5L MTDH | 8.79e-06 | 463 | 129 | 13 | int:MYBBP1A |
| Interaction | EFCAB12 interactions | 8.80e-06 | 7 | 129 | 3 | int:EFCAB12 | |
| Interaction | HP1BP3 interactions | 8.91e-06 | 329 | 129 | 11 | int:HP1BP3 | |
| Interaction | WDR12 interactions | 9.81e-06 | 162 | 129 | 8 | int:WDR12 | |
| Interaction | SCARNA22 interactions | 1.09e-05 | 118 | 129 | 7 | int:SCARNA22 | |
| Interaction | IRAK4 interactions | 1.10e-05 | 46 | 129 | 5 | int:IRAK4 | |
| Interaction | SRSF5 interactions | CHMP4C CUL1 H1-10 GTPBP10 ADARB1 HNRNPC HP1BP3 H1-2 H1-3 H1-4 H1-1 CDC5L MTDH | 1.13e-05 | 474 | 129 | 13 | int:SRSF5 |
| Interaction | CEBPB interactions | H1-10 FLNA FLNB CEBPG TCOF1 PEX1 CCT4 HNRNPC HP1BP3 DDX46 AHNAK H1-2 H1-3 H1-4 RBM14 ASPM H1-5 TMPO ZFR MPHOSPH10 CDC5L MTDH THRAP3 NUP153 | 1.35e-05 | 1443 | 129 | 24 | int:CEBPB |
| Interaction | NCL interactions | CHMP4C CUL1 H1-10 FLNA FLNB CAPN6 ADARB1 H1-2 H1-3 H1-4 H1-5 TMPO H1-1 HERC2 CDC5L MTDH THRAP3 | 1.36e-05 | 798 | 129 | 17 | int:NCL |
| Interaction | BTF3 interactions | FLNA MYH2 FLNB TCOF1 ITSN1 CCT4 HNRNPC CASZ1 AHNAK H1-2 H1-4 RBM14 H1-5 TMPO H1-1 HERC2 THRAP3 | 1.38e-05 | 799 | 129 | 17 | int:BTF3 |
| Interaction | SNRNP40 interactions | FLNA TCOF1 POLH GPATCH1 HNRNPC BLM CDCA2 H1-2 ZNF667 H1-4 RBM14 MPHOSPH10 CDC5L FSCN1 MTDH | 1.43e-05 | 637 | 129 | 15 | int:SNRNP40 |
| Interaction | EFTUD2 interactions | CHMP4C H1-10 FLNA FLNB TCOF1 GPATCH1 NARS1 CCT4 GTPBP10 ADARB1 HNRNPC HP1BP3 MORF4L2 AHNAK H1-2 RBM14 H1-5 ALDH18A1 TMPO CDC5L FSCN1 MTDH THRAP3 AHNAK2 | 1.45e-05 | 1449 | 129 | 24 | int:EFTUD2 |
| Interaction | HECTD1 interactions | H1-10 GPATCH1 CAPN6 GTPBP10 HP1BP3 BLM CDCA2 DDX46 MDN1 MORF4L2 H1-4 RBM14 ASPM TMPO ZFR MPHOSPH10 HERC2 CDC5L MTDH | 1.62e-05 | 984 | 129 | 19 | int:HECTD1 |
| Interaction | MCM5 interactions | FLNA FLNB ZBTB38 HNRNPC MORF4L2 H1-2 H1-3 H1-4 TMPO H1-1 CDC5L THRAP3 | 1.67e-05 | 420 | 129 | 12 | int:MCM5 |
| Interaction | ISG15 interactions | FLNA FLNB MYH7B CCT4 HP1BP3 USP21 NSFL1C AHNAK PAFAH1B1 TMPO MTDH THRAP3 AHNAK2 | 1.75e-05 | 494 | 129 | 13 | int:ISG15 |
| Interaction | H3C1 interactions | H1-10 ASH1L SPAG9 HP1BP3 BLM CDCA2 ADSS2 AHNAK H1-2 H1-3 H1-4 H1-5 NAV3 NAV2 TMPO ZFR H1-1 THRAP3 | 1.76e-05 | 901 | 129 | 18 | int:H3C1 |
| Interaction | NMNAT1 interactions | 1.86e-05 | 128 | 129 | 7 | int:NMNAT1 | |
| Interaction | DISC1 interactions | AKAP6 FLNA ITSN1 HNRNPC BICD1 MORF4L2 PAFAH1B1 RBM14 HERC2 CDC5L CLEC16A MTDH | 2.06e-05 | 429 | 129 | 12 | int:DISC1 |
| Interaction | LMNA interactions | CHMP4C CUL1 FLNA GPATCH1 ADARB1 HNRNPC HP1BP3 CDCA2 DDX46 MORF4L2 H1-2 H1-4 RBM14 H1-5 TMPO H1-1 HERC2 CDC5L MTDH THRAP3 NUP153 ZNF239 | 2.13e-05 | 1286 | 129 | 22 | int:LMNA |
| Interaction | SREK1 interactions | 2.37e-05 | 183 | 129 | 8 | int:SREK1 | |
| Interaction | ZCRB1 interactions | 2.50e-05 | 134 | 129 | 7 | int:ZCRB1 | |
| Interaction | MYH9 interactions | CUL1 FLNA FLNB MYLK TCOF1 TEX2 SPAG9 MUC13 ADARB1 AFAP1 NSFL1C AHNAK TMPO CDC5L DNAH5 MTDH | 2.61e-05 | 754 | 129 | 16 | int:MYH9 |
| Interaction | LARP7 interactions | H1-10 FLNA SLF1 TCOF1 PEX1 CCT4 SPAG9 HNRNPC HP1BP3 DDX46 H1-2 H1-3 H1-4 RBM14 H1-5 ZFR H1-1 CDC5L THRAP3 NUP153 | 2.66e-05 | 1113 | 129 | 20 | int:LARP7 |
| Interaction | NOC3L interactions | 2.80e-05 | 244 | 129 | 9 | int:NOC3L | |
| Interaction | YWHAQ interactions | CHMP4C FLNA MYH2 ZBTB38 MAP2 SPAG9 N4BP3 HNRNPC RGS12 ADSS2 H1-2 CCSER2 H1-3 RBM14 NAV2 TMPO H1-1 LRBA CDC5L FSCN1 | 2.83e-05 | 1118 | 129 | 20 | int:YWHAQ |
| Interaction | ELAVL2 interactions | 2.88e-05 | 188 | 129 | 8 | int:ELAVL2 | |
| Interaction | FBXW7 interactions | FOXM1 CUL1 H1-10 FLNA NUBP1 HNRNPC HP1BP3 BLM ADSS2 MORF4L2 AHNAK H1-4 RBM14 H1-5 ALDH18A1 TMPO ZFR HERC2 LSM14B MTDH THRAP3 | 2.90e-05 | 1215 | 129 | 21 | int:FBXW7 |
| Interaction | REV3L interactions | 2.92e-05 | 56 | 129 | 5 | int:REV3L | |
| Interaction | USP7 interactions | FOXM1 CUL1 ZBTB38 FAT3 POLH ADARB1 HNRNPC USP21 TENM4 MDN1 AHNAK RBM14 ASPM NAV2 ZFHX2 FGF2 TMPO ZFR LRBA CDC5L DNAH5 THRAP3 | 2.93e-05 | 1313 | 129 | 22 | int:USP7 |
| Interaction | TMPO interactions | CHMP4C FLNA TEX2 RGPD1 CCT4 ADARB1 HNRNPC HP1BP3 DDX46 AHNAK H1-4 RBM14 TMPO CDC5L CLEC16A MTDH | 2.96e-05 | 762 | 129 | 16 | int:TMPO |
| Interaction | MEN1 interactions | CUL1 H1-10 DRG2 TCOF1 GPATCH1 HNRNPC HP1BP3 DDX46 MDN1 NSFL1C ZNF592 SETBP1 RBM14 ALDH18A1 ZFR MPHOSPH10 MTDH THRAP3 NUP153 | 2.99e-05 | 1029 | 129 | 19 | int:MEN1 |
| Interaction | AATF interactions | H1-10 EVPL ADARB1 HNRNPC H1-2 H1-3 H1-4 ZFR H1-1 MPHOSPH10 THRAP3 | 3.07e-05 | 376 | 129 | 11 | int:AATF |
| Interaction | HELLS interactions | 3.35e-05 | 192 | 129 | 8 | int:HELLS | |
| GeneFamily | Histones | 1.93e-06 | 116 | 91 | 7 | 864 | |
| GeneFamily | Myosin heavy chains | 5.37e-05 | 15 | 91 | 3 | 1098 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CUL1 FLNB MTF2 ITSN1 ADARB1 BLM AFAP1 MDN1 PAFAH1B1 CCSER2 FGF2 CLEC16A NUP153 | 5.95e-07 | 466 | 130 | 13 | M13522 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | MYH6 ABCA2 CEBPG MAP2 MTF2 CAPN6 ABCC5 NUBP1 TENM4 CCDC71 GZMH NAV2 ZFR FSCN1 THRAP3 | 1.79e-06 | 690 | 130 | 15 | M12224 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CUL1 FLNB MTF2 ITSN1 SPAG9 ADARB1 BICD1 BLM AFAP1 MDN1 PAFAH1B1 CCSER2 NAV3 FGF2 CLEC16A NUP153 | 5.49e-06 | 856 | 130 | 16 | M4500 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | FOXM1 CEBPG MAP2 TCOF1 MTF2 NUBP1 ATXN7L3 MDN1 NSFL1C MORF4L2 TXNRD3 ALDH18A1 TMPO MPHOSPH10 WDR13 | 7.40e-06 | 776 | 130 | 15 | M1107 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | FOXM1 H1-10 SLF1 MTF2 NEXMIF BICD1 BLM CDCA2 MORF4L2 ASPM H1-5 ALDH18A1 TMPO ZNF239 | 7.50e-06 | 680 | 130 | 14 | MM456 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | FOXM1 CEBPG MAP2 TCOF1 MTF2 NUBP1 ATXN7L3 MDN1 NSFL1C MORF4L2 TXNRD3 ALDH18A1 TMPO MPHOSPH10 WDR13 | 9.71e-06 | 794 | 130 | 15 | MM982 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.01e-05 | 276 | 130 | 9 | M3063 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | MYH6 ABCA2 CEBPG MAP2 MTF2 CAPN6 ABCC5 NUBP1 TENM4 CCDC71 NAV2 ZFR FSCN1 THRAP3 | 1.96e-05 | 741 | 130 | 14 | MM1037 |
| Coexpression | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP | 1.98e-05 | 166 | 130 | 7 | M4288 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | FLNB ABCA2 MYLK TEX2 CAPN6 PEX1 ABCC5 CCT4 TPGS2 CDCA2 AFAP1 PAFAH1B1 H1-2 NAV3 NAV2 AK1 ZFR | 3.28e-05 | 1102 | 130 | 17 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | FLNB ABCA2 MYLK TEX2 CAPN6 PEX1 ABCC5 CCT4 TPGS2 CDCA2 AFAP1 PAFAH1B1 H1-2 NAV3 NAV2 AK1 ZFR | 4.20e-05 | 1124 | 130 | 17 | MM1070 |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | TCOF1 MRPL27 NARS1 NUBP1 CCT4 HNRNPC HP1BP3 DDX46 MORF4L2 PAFAH1B1 H1-2 CMA1 TMPO CDC5L MTDH THRAP3 ADSS1 | 5.23e-05 | 1144 | 130 | 17 | MM3843 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | TEX2 CCT4 ARMC9 TPGS2 HNRNPC MDN1 ASPM ALDH18A1 TMPO ZFR MTDH NUP153 | 5.56e-05 | 612 | 130 | 12 | M4772 |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP | 6.29e-05 | 199 | 130 | 7 | M4278 | |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | 6.29e-05 | 199 | 130 | 7 | M6932 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | FOXM1 FLNA ZBTB38 CEBPG POLH GTPBP10 MORF4L2 AHNAK ASPM TMPO MPHOSPH10 CDC5L AHNAK2 | 6.34e-05 | 721 | 130 | 13 | M10237 |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DN | 6.49e-05 | 200 | 130 | 7 | M4949 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | MAP2 CAPN6 ABCC5 NUBP1 ADH1C MSR1 CCDC71 GZMH H1-2 CMA1 ZFR FSCN1 | 6.69e-05 | 624 | 130 | 12 | M4371 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | FOXM1 CUL1 SLF1 NEXMIF TMEM132B HNRNPC USP21 BLM CDCA2 AMER2 ADSS2 NSFL1C RBM14 ASPM TMPO CDC5L MTDH NUP153 | 6.96e-05 | 1290 | 130 | 18 | M80 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ZBTB38 CEBPG MAP2 NEXMIF ASH1L CCT4 TMEM132B HNRNPC SETBP1 PAFAH1B1 CCSER2 NAV2 GREM1 CDC5L DNAH5 | 7.28e-05 | 946 | 130 | 15 | M39169 |
| Coexpression | FISCHER_DREAM_TARGETS | FOXM1 SLF1 TCOF1 MTF2 SPAG9 BLM CDCA2 DDX46 H1-2 H1-3 ASPM H1-5 TMPO THRAP3 NUP153 | 9.50e-05 | 969 | 130 | 15 | M149 |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | 1.05e-04 | 461 | 130 | 10 | M14127 | |
| Coexpression | JONES_OVARY_GRANULOSA | 1.18e-04 | 96 | 130 | 5 | M48347 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 1.27e-04 | 155 | 130 | 6 | M39041 | |
| Coexpression | SANSOM_APC_TARGETS_REQUIRE_MYC | 1.35e-04 | 225 | 130 | 7 | M1757 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | SLF1 ZSWIM3 SPAG9 TPGS2 BICD1 BLM PAFAH1B1 ASPM FGF2 TMPO HERC2 LSM14B MTDH EDRF1 | 1.43e-04 | 892 | 130 | 14 | M18120 |
| Coexpression | SANSOM_APC_TARGETS_REQUIRE_MYC | 1.59e-04 | 231 | 130 | 7 | MM737 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 1.67e-04 | 163 | 130 | 6 | M8235 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | MAP2 CAPN6 ABCC5 NUBP1 ADH1C MSR1 CCDC71 GZMH H1-2 CMA1 ZFR FSCN1 | 1.81e-04 | 694 | 130 | 12 | MM1039 |
| Coexpression | OSMAN_BLADDER_CANCER_UP | 1.85e-04 | 402 | 130 | 9 | M5275 | |
| Coexpression | ALFANO_MYC_TARGETS | 1.96e-04 | 239 | 130 | 7 | M2477 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K3 | FOXM1 H1-10 DRG2 TCOF1 MTF2 NUBP1 CCT4 N4BP3 FREM1 BLM CDCA2 MDN1 CCDC71 H1-2 H1-3 H1-4 H1-5 AK1 H1-1 LRBA FSCN1 | 2.28e-05 | 1259 | 129 | 21 | facebase_RNAseq_e9.5_MandArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#3 | 5.16e-05 | 108 | 129 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 6.80e-05 | 165 | 129 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | MYLK FAT3 CAPN6 ASH1L ABCC5 CDCA2 TENM4 PAFAH1B1 ADAMTS16 ASPM NAV2 ZFR ATP1A2 THRAP3 AHNAK2 | 9.22e-05 | 790 | 129 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | FLNA ANKS6 MSRB1 MAP2 MYH7B NEXMIF FAT3 GPATCH1 CAPN6 FREM1 USP21 TENM4 SETBP1 ZNF667 NAV3 FGF2 ALDH18A1 ZFR EGFLAM | 1.27e-04 | 1208 | 129 | 19 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_500 | 1.32e-04 | 388 | 129 | 10 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500 | |
| CoexpressionAtlas | Stem Cells, SC.GMP.BM, Lineage- sca1- ckithi CD34+ FcgRhi, Bone marrow, avg-3 | 1.36e-04 | 81 | 129 | 5 | GSM791119_100 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | AKAP6 MYH6 ZBTB38 ECM2 AHNAK PAFAH1B1 H1-4 ZFR ATP1A2 THRAP3 | 1.15e-10 | 176 | 130 | 10 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 2.99e-10 | 194 | 130 | 10 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.28e-09 | 195 | 130 | 9 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 6.57e-09 | 196 | 130 | 9 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 7.83e-09 | 200 | 130 | 9 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 7.83e-09 | 200 | 130 | 9 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG|World / Primary Cells by Cluster | 7.83e-09 | 200 | 130 | 9 | 7596143925cd403ec7baceef87d19d570e48586a | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 7.83e-09 | 200 | 130 | 9 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.02e-08 | 180 | 130 | 8 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-08 | 186 | 130 | 8 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-08 | 186 | 130 | 8 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.08e-08 | 187 | 130 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.77e-08 | 189 | 130 | 8 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 9.51e-08 | 191 | 130 | 8 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.11e-07 | 195 | 130 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.12e-07 | 130 | 130 | 7 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 1.16e-07 | 196 | 130 | 8 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-07 | 196 | 130 | 8 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-07 | 197 | 130 | 8 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-07 | 197 | 130 | 8 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 1.30e-07 | 199 | 130 | 8 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 1.30e-07 | 199 | 130 | 8 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 1.35e-07 | 200 | 130 | 8 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.35e-07 | 200 | 130 | 8 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-07 | 200 | 130 | 8 | 3c3ac587ad98e3f6be809eac18c7742a23140de1 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-07 | 200 | 130 | 8 | 5c84aaedac9f27da0da0493dab7c8f7a4d66888c | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.35e-07 | 200 | 130 | 8 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-07 | 200 | 130 | 8 | dd7ad295ab3ba4c19babffb1625900db414bb5a9 | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-07 | 200 | 130 | 8 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | moderate-Lymphoid-NKT-proliferating|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.35e-07 | 200 | 130 | 8 | 8692e6664f0bb2be990f7563888380bb47414626 | |
| ToppCell | Tuft-tuft-4|World / Class top | 8.12e-07 | 174 | 130 | 7 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-07 | 179 | 130 | 7 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.82e-07 | 179 | 130 | 7 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 184 | 130 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-06 | 184 | 130 | 7 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 184 | 130 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 184 | 130 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-06 | 184 | 130 | 7 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.22e-06 | 185 | 130 | 7 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.31e-06 | 187 | 130 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.36e-06 | 188 | 130 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 1.36e-06 | 188 | 130 | 7 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.41e-06 | 189 | 130 | 7 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.41e-06 | 189 | 130 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 189 | 130 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 190 | 130 | 7 | 185ae04c68f825cd346aa65072cc5da6a39dff4a | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.46e-06 | 190 | 130 | 7 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 190 | 130 | 7 | e38dc41f2e79e3bd51326581c6ebe51927edb549 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 191 | 130 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-06 | 191 | 130 | 7 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 1.51e-06 | 191 | 130 | 7 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.51e-06 | 191 | 130 | 7 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-06 | 191 | 130 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 191 | 130 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.57e-06 | 192 | 130 | 7 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.57e-06 | 192 | 130 | 7 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.57e-06 | 192 | 130 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.57e-06 | 192 | 130 | 7 | 5ef79faddb433c09ff36660d8bf7a3af5a67bf1d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.57e-06 | 192 | 130 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-06 | 193 | 130 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-06 | 194 | 130 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.68e-06 | 194 | 130 | 7 | 4a207630d72059345b10010f5cfd3b1462458324 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.68e-06 | 194 | 130 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.68e-06 | 194 | 130 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.68e-06 | 194 | 130 | 7 | d840c1949c328779426c9172e02da09e968f0567 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 195 | 130 | 7 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.74e-06 | 195 | 130 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-06 | 195 | 130 | 7 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.80e-06 | 196 | 130 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-06 | 196 | 130 | 7 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-06 | 196 | 130 | 7 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.86e-06 | 197 | 130 | 7 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.86e-06 | 197 | 130 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.86e-06 | 197 | 130 | 7 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-06 | 197 | 130 | 7 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | BL-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.86e-06 | 197 | 130 | 7 | fb70918867fbd111bb192a797dcafed5f39ea299 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-06 | 197 | 130 | 7 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-06 | 197 | 130 | 7 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-06 | 197 | 130 | 7 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.86e-06 | 197 | 130 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-06 | 197 | 130 | 7 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.86e-06 | 197 | 130 | 7 | 04b10879e48c101d1de449db0bc6b6484090b965 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-06 | 197 | 130 | 7 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | BL-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.92e-06 | 198 | 130 | 7 | 1c0227e58a64c0bf509bfb9578fb91277316b120 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 198 | 130 | 7 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-06 | 198 | 130 | 7 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-06 | 198 | 130 | 7 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 198 | 130 | 7 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-06 | 199 | 130 | 7 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 1.99e-06 | 199 | 130 | 7 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | Severe|World / Disease group and Cell class | 1.99e-06 | 199 | 130 | 7 | b73ae402b258fcc17e6cd6d6045244eccfe38ef8 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.99e-06 | 199 | 130 | 7 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 130 | 7 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.06e-06 | 200 | 130 | 7 | 535f6fba8d03873ba35c9949579161dc41cd7a60 | |
| ToppCell | Severe_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.06e-06 | 200 | 130 | 7 | 52265e761a961f3724b388285e0919bd58847138 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.06e-06 | 200 | 130 | 7 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 130 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells-Neuroepithelial_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.06e-06 | 200 | 130 | 7 | c865efaaaecccbf9c833d6c1cbe85809a3ec306d | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 130 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 130 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.78e-05 | 50 | 93 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | NSC611747 | FLNA MYH2 MYH6 MYLK MYH7B NSFL1C SETBP1 H1-2 H1-3 H1-4 H1-5 ZFR H1-1 LRBA | 1.35e-08 | 352 | 129 | 14 | CID000002534 |
| Drug | NSC-629231 | 2.57e-08 | 55 | 129 | 7 | CID000363885 | |
| Drug | Kemptide | 3.72e-08 | 124 | 129 | 9 | CID000100074 | |
| Drug | Spkk | 1.51e-07 | 43 | 129 | 6 | CID000129363 | |
| Drug | syntide-2 | 1.57e-07 | 71 | 129 | 7 | CID005074902 | |
| Drug | 5-methyl-dCTP | 6.80e-07 | 55 | 129 | 6 | CID000161376 | |
| Drug | AC1L9MGN | 1.13e-06 | 33 | 129 | 5 | CID000448889 | |
| Drug | MMPR | 1.13e-06 | 33 | 129 | 5 | CID000009570 | |
| Drug | gold sodium thiomalate | 1.40e-06 | 62 | 129 | 6 | CID000022318 | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.53e-06 | 192 | 129 | 9 | 4274_DN | |
| Drug | 3-tert-butylphenyl-N-methyl-carbamate | 1.77e-06 | 36 | 129 | 5 | CID000013072 | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.82e-06 | 196 | 129 | 9 | 5293_DN | |
| Drug | F2-b | 2.02e-06 | 66 | 129 | 6 | CID000001700 | |
| Drug | heparin disaccharide iii-S | 2.04e-06 | 37 | 129 | 5 | CID000448838 | |
| Drug | GH 5 | 5.50e-06 | 45 | 129 | 5 | CID000163897 | |
| Drug | MgCl2 | 5.70e-06 | 354 | 129 | 11 | CID000024584 | |
| Drug | N-myristoyl-rkrtlrrl | 6.15e-06 | 46 | 129 | 5 | CID003081274 | |
| Drug | Chr 5 | 7.29e-06 | 125 | 129 | 7 | CID006448119 | |
| Drug | Scriptaid | 7.61e-06 | 48 | 129 | 5 | CID000005186 | |
| Drug | butyrolactone I | 8.52e-06 | 128 | 129 | 7 | CID000123740 | |
| Drug | belinostat | 9.33e-06 | 50 | 129 | 5 | CID006918638 | |
| Drug | SN-38 | 1.04e-05 | 184 | 129 | 8 | CID000104842 | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.17e-05 | 187 | 129 | 8 | 4323_DN | |
| Drug | AC1Q6AQ7 | 1.21e-05 | 188 | 129 | 8 | CID000005515 | |
| Drug | CAS 1400-61-9 | 1.25e-05 | 53 | 129 | 5 | CID000004568 | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 1.26e-05 | 189 | 129 | 8 | 5084_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.36e-05 | 191 | 129 | 8 | 4283_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.36e-05 | 191 | 129 | 8 | 4273_DN | |
| Drug | 8-bromoguanosine | 1.50e-05 | 93 | 129 | 6 | CID000092977 | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.58e-05 | 195 | 129 | 8 | 3237_DN | |
| Drug | AC1N9ZZC | 2.29e-05 | 149 | 129 | 7 | CID004369374 | |
| Drug | SK-7041 | 2.30e-05 | 60 | 129 | 5 | CID006918714 | |
| Drug | AC1LAPI9 | 3.19e-05 | 2 | 129 | 2 | CID000472615 | |
| Drug | chrysene | MYLK TCOF1 VPS39 GPATCH1 ABCC5 CASZ1 RGS12 MSR1 TENM4 MDN1 NSFL1C AHNAK H1-2 H1-4 H1-1 THRAP3 | 3.44e-05 | 871 | 129 | 16 | ctd:C031180 |
| Drug | CGP 41251 | 3.51e-05 | 108 | 129 | 6 | CID000104937 | |
| Drug | LBH589 | 3.70e-05 | 109 | 129 | 6 | CID006918837 | |
| Drug | AlCl3 | 4.53e-05 | 113 | 129 | 6 | CID000024012 | |
| Drug | Apicidin | 4.53e-05 | 113 | 129 | 6 | CID000467801 | |
| Drug | daunorubicin HCl; Up 200; 1uM; MCF7; HT_HG-U133A | 6.62e-05 | 176 | 129 | 7 | 7525_UP | |
| Drug | benz(a)anthracene | ZBTB38 TCOF1 VPS39 POLH ITSN1 ABCC5 HNRNPC RGS12 FREM1 MSR1 MDN1 AHNAK H1-2 H1-4 MPHOSPH10 LSM14B THRAP3 LRRC71 AHNAK2 | 8.07e-05 | 1251 | 129 | 19 | ctd:C030935 |
| Drug | Trapoxin B | 8.70e-05 | 79 | 129 | 5 | CID000005532 | |
| Drug | NaCl | MAP2 POLH H1-2 H1-3 H1-4 TXNRD3 H1-5 NAV2 FGF2 ALDH18A1 H1-1 ATP1A2 | 8.96e-05 | 564 | 129 | 12 | CID000005234 |
| Drug | Ps 9 | 9.52e-05 | 3 | 129 | 2 | CID000066348 | |
| Drug | alanosyl-AICOR | 9.52e-05 | 3 | 129 | 2 | CID000127520 | |
| Drug | phosphohydantocidin | 9.52e-05 | 3 | 129 | 2 | CID000446561 | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 1.00e-04 | 188 | 129 | 7 | 4310_DN | |
| Drug | DADS | 1.03e-04 | 131 | 129 | 6 | CID000016590 | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.04e-04 | 189 | 129 | 7 | 4304_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 189 | 129 | 7 | 3214_DN | |
| Drug | C04378 | 1.04e-04 | 82 | 129 | 5 | CID000440315 | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 190 | 129 | 7 | 2296_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.07e-04 | 190 | 129 | 7 | 4307_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.11e-04 | 191 | 129 | 7 | 4303_DN | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 1.11e-04 | 191 | 129 | 7 | 7525_DN | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 1.11e-04 | 191 | 129 | 7 | 7507_DN | |
| Drug | chlorambucil | 1.12e-04 | 133 | 129 | 6 | CID000002708 | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.14e-04 | 192 | 129 | 7 | 3188_DN | |
| Drug | Bisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A | 1.18e-04 | 193 | 129 | 7 | 4616_DN | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.18e-04 | 193 | 129 | 7 | 4253_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.22e-04 | 194 | 129 | 7 | 4281_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.22e-04 | 194 | 129 | 7 | 3606_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.22e-04 | 194 | 129 | 7 | 4272_DN | |
| Drug | BAS 012416453; Down 200; 38uM; PC3; HT_HG-U133A | 1.22e-04 | 194 | 129 | 7 | 6876_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.22e-04 | 194 | 129 | 7 | 4312_DN | |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 7035_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 6927_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 5109_DN | |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.26e-04 | 195 | 129 | 7 | 4692_DN | |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; PC3; HT_HG-U133A | 1.30e-04 | 196 | 129 | 7 | 1801_UP | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.30e-04 | 196 | 129 | 7 | 3206_DN | |
| Drug | Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.30e-04 | 196 | 129 | 7 | 7257_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.30e-04 | 196 | 129 | 7 | 4108_DN | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.30e-04 | 196 | 129 | 7 | 5759_DN | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; HL60; HT_HG-U133A | 1.34e-04 | 197 | 129 | 7 | 3069_UP | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.34e-04 | 197 | 129 | 7 | 3579_DN | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.34e-04 | 197 | 129 | 7 | 5675_DN | |
| Drug | Benzthiazide [91-33-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.38e-04 | 198 | 129 | 7 | 4952_UP | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; HL60; HT_HG-U133A | 1.43e-04 | 199 | 129 | 7 | 2978_UP | |
| Drug | Glucose | CUL1 MYH2 MYLK NUBP1 HNRNPC CASZ1 RGS12 H1-8 DDX46 TENM4 NSFL1C ZNF592 MORF4L2 PAFAH1B1 H1-2 RBM14 FGF2 GREM1 MTDH NUP153 | 1.44e-04 | 1420 | 129 | 20 | ctd:D005947 |
| Drug | Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.47e-04 | 200 | 129 | 7 | 1692_UP | |
| Drug | Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.47e-04 | 200 | 129 | 7 | 7410_DN | |
| Drug | AC1L45LU | 1.71e-04 | 205 | 129 | 7 | CID000151069 | |
| Drug | LAQ824 | 1.79e-04 | 92 | 129 | 5 | CID006445533 | |
| Drug | penduletin | 1.90e-04 | 4 | 129 | 2 | CID005320462 | |
| Drug | TPPR-MP | 1.90e-04 | 4 | 129 | 2 | CID003036186 | |
| Drug | oleanolic aldehyde | 1.90e-04 | 4 | 129 | 2 | CID005320280 | |
| Drug | altenusin | 1.90e-04 | 4 | 129 | 2 | CID006918469 | |
| Drug | AC1L4TYZ | 1.90e-04 | 4 | 129 | 2 | CID000192227 | |
| Drug | AC1L9HHR | 1.91e-04 | 354 | 129 | 9 | CID000445141 | |
| Drug | hydroxyurea | 1.94e-04 | 436 | 129 | 10 | CID000003657 | |
| Drug | polyarginine | 2.08e-04 | 95 | 129 | 5 | CID000072364 | |
| Drug | Lucanthone | 2.10e-04 | 212 | 129 | 7 | ctd:D008154 | |
| Drug | Coal Tar | 2.17e-04 | 360 | 129 | 9 | ctd:D003033 | |
| Drug | NSC23766 | 2.41e-04 | 98 | 129 | 5 | CID000409805 | |
| Drug | thioinosinic acid | 2.90e-04 | 23 | 129 | 3 | CID003034391 | |
| Disease | myopathy (implicated_via_orthology) | 1.79e-06 | 48 | 124 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 8.51e-06 | 10 | 124 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 8.51e-06 | 10 | 124 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 8.51e-06 | 10 | 124 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 8.51e-06 | 10 | 124 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 8.51e-06 | 10 | 124 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 8.51e-06 | 10 | 124 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 8.51e-06 | 10 | 124 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 8.51e-06 | 10 | 124 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.55e-05 | 12 | 124 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.55e-05 | 12 | 124 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | spondylocarpotarsal synostosis syndrome (implicated_via_orthology) | 1.75e-05 | 2 | 124 | 2 | DOID:0090116 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.01e-05 | 13 | 124 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.18e-05 | 15 | 124 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | AKAP6 MAP2 TCOF1 CAPN6 ABCC5 AMER2 SETBP1 H1-4 H1-5 GREM1 MTDH EDRF1 | 4.21e-05 | 702 | 124 | 12 | C0009402 |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 5.24e-05 | 3 | 124 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 5.24e-05 | 3 | 124 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | sarcoma (biomarker_via_orthology) | 5.24e-05 | 3 | 124 | 2 | DOID:1115 (biomarker_via_orthology) | |
| Disease | cardiovascular disease biomarker measurement, ankle brachial index | 1.74e-04 | 5 | 124 | 2 | EFO_0003912, EFO_0005278 | |
| Disease | synophrys measurement | 1.97e-04 | 68 | 124 | 4 | EFO_0007906 | |
| Disease | serum gamma-glutamyl transferase measurement | PLB1 CEBPG MTF2 GPATCH1 ASH1L NARS1 USP21 TENM4 AHNAK NAV2 LRBA LSM14B | 4.83e-04 | 914 | 124 | 12 | EFO_0004532 |
| Disease | response to carboplatin, response to antineoplastic agent | 7.71e-04 | 10 | 124 | 2 | GO_0097327, GO_0097328 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.35e-03 | 286 | 124 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | Inguinal hernia | 1.38e-03 | 287 | 124 | 6 | HP_0000023 | |
| Disease | response to methotrexate, aspartate aminotransferase measurement | 1.54e-03 | 14 | 124 | 2 | EFO_0004736, GO_0031427 | |
| Disease | brain connectivity measurement | 1.55e-03 | 400 | 124 | 7 | EFO_0005210 | |
| Disease | vascular endothelial growth factor measurement | 1.71e-03 | 56 | 124 | 3 | EFO_0004762 | |
| Disease | neuroimaging measurement | MAP2 FAT3 RGPD1 ARMC9 HP1BP3 BICD1 AMER2 AFAP1 H1-2 NAV3 NAV2 CDC5L | 1.85e-03 | 1069 | 124 | 12 | EFO_0004346 |
| Disease | microglial activation measurement | 1.98e-03 | 59 | 124 | 3 | EFO_0010940 | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.98e-03 | 59 | 124 | 3 | EFO_0009658, GO_0009410 | |
| Disease | respiratory symptom change measurement, response to placebo | 2.29e-03 | 17 | 124 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | brain measurement, neuroimaging measurement | 2.31e-03 | 550 | 124 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 2.86e-03 | 19 | 124 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.36e-03 | 71 | 124 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 3.83e-03 | 22 | 124 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | mean platelet volume | CHMP4C LRRC66 ZBTB38 TEX2 PROCA1 ABCC5 RGS12 AFAP1 MORF4L2 SETBP1 PAFAH1B1 | 3.88e-03 | 1020 | 124 | 11 | EFO_0004584 |
| Disease | Schizophrenia | MSRB1 VPS39 ADARB1 RGS12 TENM4 ADSS2 PAFAH1B1 H1-4 H1-5 FGF2 | 4.16e-03 | 883 | 124 | 10 | C0036341 |
| Disease | triacylglycerol 54:8 measurement | 4.18e-03 | 23 | 124 | 2 | EFO_0010426 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSIFGVKNKGDGKSS | 81 | Q8N7J2 | |
| PTKLAASTKGGKDKG | 1236 | Q6ZSZ5 | |
| KPKKLGTGTTAGLVS | 236 | Q9NR48 | |
| GTTAVFINKNLGKKP | 311 | Q9NR48 | |
| FINKNLGKKPGTITT | 316 | Q9NR48 | |
| GNKKGKTVGFGTNNS | 596 | Q99459 | |
| KKNSGVLKPFSGSIQ | 746 | Q63HQ2 | |
| LGKSKIGSPKVSGEA | 811 | Q96G01 | |
| GAIAFKTGKVGRPSK | 361 | Q86V15 | |
| KGAIFGGFKSKESVP | 316 | P00326 | |
| NGVTGKGKTLSSQPK | 521 | Q8N556 | |
| GTGASGSFKLNKKAS | 101 | Q02539 | |
| ICVGDPKKTQTGFKG | 186 | P20718 | |
| TKGTGASGSFKLNKK | 96 | P16403 | |
| KFNFSKPKGKGGVTG | 5716 | Q09666 | |
| GKLQGSGVSLASKKS | 5846 | Q09666 | |
| GTKEPKKGQGSLFLS | 341 | Q6P1W5 | |
| KFFKGGGSSKSRAAP | 6 | Q96CF2 | |
| KPGNKVADKGGSIFT | 3356 | Q8IZT6 | |
| SLVGTASGLGSNKKK | 316 | Q14CW9 | |
| PGFIVQTLGKTGTKS | 121 | Q8TE57 | |
| GASGTFQLKKSGEKP | 321 | Q5SSJ5 | |
| FQLKKSGEKPLLGGS | 326 | Q5SSJ5 | |
| FATTTKRGGALKKGP | 156 | Q9Y483 | |
| QKKGPGLAVQSGDKT | 151 | Q96PK6 | |
| GLAVQSGDKTKKPGA | 156 | Q96PK6 | |
| SGDKTKKPGAGDTAF | 161 | Q96PK6 | |
| TKKSGKPGPFLLSGS | 301 | P43034 | |
| KGSSTPTKGIENKAF | 361 | O60271 | |
| KTGGKNVSGKPKTVT | 111 | Q9UPP5 | |
| KILVLSGKGGVGKST | 56 | P53384 | |
| GGKKKLPAENGSSSA | 986 | Q15746 | |
| GSQTGGFAGIKKLQK | 2786 | Q9NU22 | |
| NTKAAAPAKGSGSKV | 296 | Q8IZA3 | |
| KSGQRGSSKSGKLKG | 176 | P07910 | |
| KQPGASVKVSCKASG | 31 | A0A0B4J1V7 | |
| NKLASTPFKGGTLFG | 666 | P42166 | |
| GTLLPAAEGKKKGSQ | 16 | O60565 | |
| KLGPAGTTILGNSKK | 86 | Q3B7T1 | |
| QLGGLKGSKIKVPSF | 2971 | O95714 | |
| KKTKIIFVVGGPGSG | 6 | P00568 | |
| VTKAGGSAALSPSKK | 21 | Q92522 | |
| AKKLLPGKGTTGTQL | 171 | Q9BX40 | |
| KIKGKPLCKTVGGSF | 36 | Q7Z3E5 | |
| LGGGTATLKASNFKP | 491 | Q9BRR8 | |
| SKVKAEGPGLSKAGV | 846 | O75369 | |
| TSKGAGLSKAFVGQK | 2516 | O75369 | |
| PGKKAQFLATKTGGT | 246 | A7E2Y1 | |
| KGGKKKGSSFQTVSA | 641 | Q9UKX2 | |
| GSHGFSLKTVQGKKG | 21 | A8MUH7 | |
| ATLGKIPKSAAIGGK | 1091 | Q8IVL0 | |
| MFKGLSKGSQGKGSP | 1 | Q92817 | |
| GSCTPGLKKIGSLKV | 221 | Q5H8C1 | |
| GGCLIVTSIKSKGKG | 271 | P50851 | |
| QFSKAKSASKGPVGL | 501 | Q8N4P6 | |
| GASSGKKTAGPQQKN | 36 | Q15014 | |
| EGGLFGSKKLKSGKS | 246 | O00566 | |
| PKGAFKAFTGEGQKL | 246 | Q9UNZ2 | |
| NGQVFEGSGPTKKKA | 116 | P78563 | |
| GISTLGKKAKAGSGL | 331 | Q68CR7 | |
| GKKVGTFFSEVKPAG | 346 | P54886 | |
| GEKGSGNTLTPFTKV | 336 | P21757 | |
| SGSQKKSQDKGPKTG | 801 | O15440 | |
| KSFSGPSNLGKFTKG | 141 | Q9H7U1 | |
| PAATTAENGGGKKKQ | 11 | P50993 | |
| KGGSALGTKTAQAKV | 271 | Q8IV32 | |
| GKPSAIFKISGLKSG | 76 | Q53FT3 | |
| VGANSKISALKGSKG | 71 | A4D1E9 | |
| PAGGKGLALSSNKVK | 266 | Q8TE85 | |
| GTGASGSFKLNKKAA | 101 | P16401 | |
| SKSAKIQSGIFGKGS | 1121 | P54132 | |
| PSGTLKAGKATKVGK | 236 | Q16658 | |
| FTVKSKGAGGQGKVA | 991 | P21333 | |
| KSKKGQTPGGAQFVG | 71 | Q13616 | |
| AGKTGSLGKKPEIAQ | 1066 | Q15811 | |
| NPGNKFKIKSTSGVI | 2021 | Q8TDW7 | |
| QGKFKINPKTGGISV | 3281 | Q8TDW7 | |
| KPAGTYSGGNKRKLS | 2181 | Q9BZC7 | |
| TKTKGPGDKQKSYQG | 216 | Q5T1N1 | |
| AGGSAPVGKKLETSK | 706 | Q68DC2 | |
| KNNITSSGIGPKAFK | 376 | O94769 | |
| TTASFPVGSKKNKGD | 236 | Q86UE4 | |
| KGGTPVCKKDFSGLS | 416 | Q69YH5 | |
| LTAKGKESGSSGPNK | 91 | Q08050 | |
| KRTGQYKLGSKTGPG | 261 | P09038 | |
| YKLGSKTGPGQKAIL | 266 | P09038 | |
| TKGTGASGSFKLNKK | 96 | P10412 | |
| GGNEKKSGPTVTKVV | 251 | Q7L014 | |
| GASGSFKLNKKAASG | 101 | P16402 | |
| KGGPTAKVKQGHISF | 616 | Q9Y6Q1 | |
| LLTGGKGSGKSTLAK | 596 | O43933 | |
| ESPTGKGQGSKVIKK | 221 | Q8NCQ7 | |
| GGGKAVAPSKQSKKS | 41 | P53567 | |
| GSLGGVNLVSGKIKK | 96 | Q8TE73 | |
| NATKGFPCLKKAQGG | 281 | Q96QI5 | |
| KSTSGEGFQFGKKDP | 961 | P0DJD0 | |
| LKFVPKGKETSASQG | 101 | Q9NZV6 | |
| GLGLVLTTPGKKKGS | 5016 | O75445 | |
| EGKNIGTTKKGIGPT | 156 | Q8N142 | |
| ATGDGTKEKPFKTGL | 16 | O43776 | |
| GKNKLLKSGGPDAFT | 856 | Q14DG7 | |
| GKAGAVASQTKAGKP | 321 | Q13428 | |
| KGVSKSNGKTAIGDP | 1396 | Q5QGS0 | |
| KIASFIPKGGKLNSA | 561 | Q8IVL1 | |
| GKLLKITGCASPGKT | 371 | P50991 | |
| STGKKVKGGSSKLTG | 291 | Q9H1Z4 | |
| PKTIGCSKNFPGKTA | 316 | Q9Y253 | |
| AKTQGSGPAVTATKK | 461 | Q9Y253 | |
| GKNLGTTKKGIGPVY | 156 | P30520 | |
| PKKGGGISFNSTVTL | 181 | P55039 | |
| LKGFSVGTGKETSPN | 451 | Q6P1J6 | |
| SKGGKKKGSSFQTVS | 636 | P13533 | |
| PKRGTGSGKQAKNTK | 511 | Q13023 | |
| VAGKDSKFQGPKLST | 4621 | Q8IVF2 | |
| NPRKTKSAFKGDSGG | 191 | P23946 | |
| KAKGTEGGSKGIKTS | 416 | Q2KHT3 | |
| GKSKSKAPITFGDLA | 6 | Q5HYK9 | |
| DKLGAKGDFPTGKSS | 546 | Q9Y2W1 | |
| SLPIPKKGFAGGKVS | 401 | Q9UK80 | |
| KKAKLQGTAAGSTGG | 2121 | Q9C0A1 | |
| KKGSKFGRGTGLTQP | 626 | O14924 | |
| NSSTCKKGKVFPGKI | 206 | Q9H3R2 | |
| KGAAPGSQTGKKQQS | 471 | Q92610 | |
| RKGKGTTEGKPSSFF | 411 | Q6N022 | |
| SLPSGGSLGLEKFKK | 836 | P49790 | |
| GKTGVLGSGKIQVSK | 716 | Q9BQI6 | |
| KIGSTDNIKYQPKGG | 1676 | P11137 | |
| NGSGKVCLVYKSGKP | 151 | Q68CL5 | |
| KTSTPKINFVGGNKL | 496 | Q96KR1 | |
| KVASPGGDTTGKSQK | 106 | Q96MP5 | |
| GSPGKLKVLAKSTEG | 406 | Q86VQ6 | |
| GNPFGTSACLKSGKK | 266 | Q9NVR7 | |
| SISKKTANGGLKPSV | 546 | Q8NAP3 | |
| GKCGKGFSQSSKLLI | 406 | Q16600 | |
| KEKKTFPISGARGGA | 76 | Q969E3 | |
| ASKKSGGSSKNLGGK | 31 | Q9P0M9 | |
| KSEIKKSSGVSGGKP | 711 | Q8IWB9 | |
| GAALFKGIKSSGKVV | 251 | Q9UN76 | |
| PVASFAKAQGKKGSA | 256 | Q9Y6X0 | |
| DGKGSIKELFPTGKQ | 191 | Q96JC1 | |
| SVFKPTAGNGKGFLS | 116 | O15049 |